{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T21:41:33Z","timestamp":1776721293283,"version":"3.51.2"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.4158\/ep-2018-0529","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T11:15:08Z","timestamp":1547810108000},"page":"485-490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Endocrine Complications in Patients with Gvhd"],"prefix":"10.1016","volume":"25","author":[{"given":"Amit","family":"Akirov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna M.","family":"Sawka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Ben-Barouch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffre y.","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shereen","family":"Ezzat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2018-0529_bb0010","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.4158\/EP-2018-0529_bb0015","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.bbmt.2005.12.035","article-title":"Altered functional status of the hypothalamic dopaminergic tone in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a pilot study","volume":"12","author":"Parra","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.4158\/EP-2018-0529_bb0020","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.bbmt.2018.02.019","article-title":"Impaired bone mineral density in pediatric patients with chronic graft-versus-host disease","volume":"24","author":"Buxbaum","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.4158\/EP-2018-0529_bb0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.pcl.2009.11.003","article-title":"Chronic graft-versus-host disease (GVHD) in children","volume":"57","author":"Baird","year":"2010","journal-title":"Pediatr Clin North Am"},{"key":"10.4158\/EP-2018-0529_bb0030","first-page":"48","article-title":"Endocrine disorders in childhood cancer survivors treated with haemopoietic stem cell transplantation","volume":"1","author":"Wei","year":"2014","journal-title":"Children (Basel)"},{"key":"10.4158\/EP-2018-0529_bb0035","doi-asserted-by":"crossref","first-page":"855","DOI":"10.4103\/2230-8210.117248","article-title":"Endocrine complications after busulphan and cyclophosphamide based hematopoietic stem cell transplant: a single tertiary care centre experience","volume":"17","author":"Gundgurthi","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"10.4158\/EP-2018-0529_bb0040","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.bbmt.2011.10.006","article-title":"NCI, NHLBI\/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: endocrine challenges-thyroid dysfunction, growth impairment, bone health, & reproductive risks","volume":"17","author":"Dvorak","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.4158\/EP-2018-0529_bb0045","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/cncr.10773","article-title":"High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases","volume":"95","author":"Tauchmanov\u00e0","year":"2002","journal-title":"Cancer"},{"key":"10.4158\/EP-2018-0529_bb0050","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.amjmed.2005.02.009","article-title":"Endocrine disorders during the first year after autologous stem-cell transplant","volume":"118","author":"Tauchmanov\u00e0","year":"2005","journal-title":"Am J Med"},{"key":"10.4158\/EP-2018-0529_bb0055","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/sj.bmt.1705374","article-title":"Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence","volume":"37","author":"Shalitin","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.4158\/EP-2018-0529_bb0060","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3346\/jkms.2013.28.1.106","article-title":"Growth after hematopoietic stem cell transplantation in children with acute myeloid leukemia","volume":"28","author":"Chung","year":"2013","journal-title":"J Korean Med Sci"},{"key":"10.4158\/EP-2018-0529_bb0065","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-2141.2002.03527.x","article-title":"Endocrine late effects after bone marrow transplant","volume":"118","author":"Brennan","year":"2002","journal-title":"Br J Haematol"},{"key":"10.4158\/EP-2018-0529_bb0070","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1651-2227.1995.tb13865.x","article-title":"Growth and endocrine disturbances after bone marrow transplantation in children","volume":"411","author":"Sklar","year":"1995","journal-title":"Acta Paediatr Suppl"},{"key":"10.4158\/EP-2018-0529_bb0075","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1182\/blood.V68.5.1129.1129","article-title":"Growth and development following marrow transplantation for leukemia","volume":"68","author":"Sanders","year":"1986","journal-title":"Blood"},{"key":"10.4158\/EP-2018-0529_bb0080","doi-asserted-by":"crossref","first-page":"282147","DOI":"10.1155\/2014\/282147","article-title":"Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells","volume":"2014","author":"Orio","year":"2014","journal-title":"Sci World J"},{"key":"10.4158\/EP-2018-0529_bb0085","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.bmt.1700643","article-title":"Growth after bone marrow transplantation in young children conditioned with chemotherapy alone","volume":"19","author":"Adan","year":"1997","journal-title":"Bone Marrow Transpl"},{"key":"10.4158\/EP-2018-0529_bb0090","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1210\/jcem-41-5-911","article-title":"Opposite effects of dexamethasone on serum concentrations of 3,3\u2032,5\u2032-triiodothyronine (reverse T3) and 3,3\u2032,5-triiodothyronine (T3)","volume":"41","author":"Chopra","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0529_bb0095","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1210\/jcem-60-4-666","article-title":"Evidence for an inhibitor of extrathyroidal conversion patients with nonthyroidal illnesses","volume":"60","author":"Chopra","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP-2018-0529_bb0100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.bbmt.2008.11.032","article-title":"Prolonged chronic graft-versus-host disease is a risk factor for thyroid failure in long-term survivors after matched sibling donor stem cell transplantation for hematologic malignancies","volume":"15","author":"Savani","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.4158\/EP-2018-0529_bb0105","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/sj.bmt.1704766","article-title":"Autoimmune thyroid dysfunction after hematopoietic stem cell transplantation","volume":"35","author":"Au","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.4158\/EP-2018-0529_bb0110","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000486034","article-title":"Endocrine and metabolic disturbances in survivors of hematopoietic stem cell transplantation in childhood and adolescence","volume":"89","author":"Shalitin","year":"2018","journal-title":"Horm Res Paediatr"},{"key":"10.4158\/EP-2018-0529_bb0115","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2006.08.9276","article-title":"Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT late effects working party study","volume":"25","author":"Cohen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.4158\/EP-2018-0529_bb0120","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/bmt.2015.63","article-title":"Secondary solid cancer screening following hematopoietic cell transplantation","volume":"50","author":"Inamoto","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"10.4158\/EP-2018-0529_bb0125","doi-asserted-by":"crossref","first-page":"747","DOI":"10.3324\/haematol.2015.140053","article-title":"Late thyroid complications in survivors of childhood acute leukemia. An L.E.A. study","volume":"101","author":"Oudin","year":"2016","journal-title":"Haematologica"},{"key":"10.4158\/EP-2018-0529_bb0130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1158\/1055-9965.EPI-11-0576","article-title":"Chemotherapy and thyroid cancer risk: a report from the childhood cancer survivor study","volume":"21","author":"Veiga","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.4158\/EP-2018-0529_bb0135","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.bbmt.2007.02.001","article-title":"Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease","volume":"13","author":"Carpenter","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.4158\/EP-2018-0529_bb0140","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.bbmt.2018.02.019","article-title":"Impaired bone mineral density in pediatric patients with chronic graft-versus-host disease","volume":"24","author":"Buxbaum","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.4158\/EP-2018-0529_bb0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000313397","article-title":"Long-term effects on bone mineral density of different therapeutic schemes for acute lymphoblastic leukemia or non-Hodgkin lymphoma during childhood","volume":"74","author":"Benmiloud","year":"2010","journal-title":"Horm Res Paediatr"},{"key":"10.4158\/EP-2018-0529_bb0150","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.bbmt.2016.01.023","article-title":"Late effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: a Children's Oncology Group report","volume":"22","author":"Chow","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.4158\/EP-2018-0529_bb0155","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/humrep\/deg295","article-title":"Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies","volume":"18","author":"Tauchmanov\u00e1","year":"2003","journal-title":"Hum Reprod"},{"key":"10.4158\/EP-2018-0529_bb0160","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13048-016-0279-y","article-title":"Reproductive issues in patients undergoing hematopoietic stem cell transplantation: an update","volume":"9","author":"Guida","year":"2016","journal-title":"J Ovarian Res"},{"key":"10.4158\/EP-2018-0529_bb0165","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1182\/blood-2006-01-0176","article-title":"Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cell transplantation is associated with age, time interval since transplantation, and apparently absence of chronic GvHD","volume":"108","author":"Rov\u00f3","year":"2006","journal-title":"Blood"},{"key":"10.4158\/EP-2018-0529_bb0170","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/sj.bmt.1702695","article-title":"Reproductive status in long-term bone marrow transplant survivors receiving busulfan-cyclophosphamide (120 mg\/kg)","volume":"26","author":"Grigg","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.4158\/EP-2018-0529_bb0175","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3324\/haematol.2012.071944","article-title":"Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation","volume":"98","author":"Rov\u00f3","year":"2013","journal-title":"Haematologica"},{"key":"10.4158\/EP-2018-0529_bb0180","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13023-014-0162-0","article-title":"Management of endocrino-metabolic dysfunctions after allogeneic hematopoietic stem cell transplantation","volume":"9","author":"Vantyghem","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.4158\/EP-2018-0529_bb0185","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ando.2006.11.002","article-title":"Effects of non-steroid immunosuppressive drugs on insulin secretion in transplantation","volume":"68","author":"Vantyghem","year":"2007","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.4158\/EP-2018-0529_bb0190","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.bmt.1704739","article-title":"Severe hypercholesterolemia mediated by lipoprotein X in patients with chronic graft-versus-host disease of the liver","volume":"35","author":"Turchin","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.4158\/EP-2018-0529_bb0195","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/bmt.2016.203","article-title":"Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT","volume":"52","author":"DeFilipp","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.4158\/EP-2018-0529_bb0200","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.bbmt.2009.05.010","article-title":"Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation","volume":"15","author":"Majhail","year":"2009","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20359073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20359073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:06:04Z","timestamp":1761516364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20359073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S1530891X20359073"],"URL":"https:\/\/doi.org\/10.4158\/ep-2018-0529","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine Complications in Patients with Gvhd","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2018-0529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}